NCT07778615Completed
Immunohistochemical Expression of Cyclin D1 in Oral Squamous Cell Carcinoma: Relationship With Clinicodemographic and Histopathological Features
Source: ClinicalTrials.gov · Last updated 21 Aug 2026
Brief summary (registry, in English)
Oral squamous cell carcinoma is a major public health problem , especially in West Asian countries. Cyclin D1 accelerates cell cycle and thus may be implicated in uncontrolled cellular proliferation and tumor progression.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 34 (actual)
- First submitted
- 18 Aug 2026
- Start date
- Jan 2017
- Primary completion date
- Dec 2025
- Lead sponsor
- Sohag University
- Diseases
- Head and neck cancer, Childhood cancers
- NCT number
- NCT07778615
What you commit to
- Study type: Observational
- Participants enrolled: 34
- From Jan 2017 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients who received pre-operative radiotherapy.
Other
- patients with oral carcinoma other than squamous cell carcinoma.
- patients with inadequate clinical data.
Who the study is looking for
- patients with oral squamous cell carcinoma.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| - Coordinator of this site? Confirm its status | Sohag | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.